Empire Life Investments Inc. Acadia Pharmaceuticals Inc Transaction History

Empire Life Investments Inc.

$1.6 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$14.62 - $18.42 $134,109 - $168,966	-9,173 Reduced 5.4%	160,662 $2.61 Million
Q1 2024 Apr 30, 2024	SELL	$17.79 - $30.86 $88,594 - $153,682	-4,980 Reduced 2.85%	169,835 $3.14 Million
Q4 2023 Feb 08, 2024	BUY	$20.78 - $31.77 $9,704 - $14,836	467 Added 0.27%	174,815 $5.47 Million
Q3 2023 Nov 09, 2023	SELL	$20.84 - $33.47 $56,559 - $90,837	-2,714 Reduced 1.53%	174,348 $3.63 Million
Q2 2023 Aug 10, 2023	SELL	$17.8 - $25.65 $8,205 - $11,824	-461 Reduced 0.26%	177,062 $4.24 Million
Q1 2023 May 08, 2023	BUY	$16.32 - $20.92 $27,450 - $35,187	1,682 Added 0.96%	177,523 $3.34 Million
Q4 2022 Feb 02, 2023	SELL	$14.2 - $18.63 $28,556 - $37,464	-2,011 Reduced 1.13%	175,841 $2.8 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $83,672 - $108,341	5,930 Added 3.45%	177,852 $2.91 Million
Q2 2022 Aug 03, 2022	BUY	$13.01 - $27.22 $42,946 - $89,853	3,301 Added 1.96%	171,922 $2.42 Million
Q1 2022 May 11, 2022	BUY	$20.94 - $27.5 $7,224 - $9,487	345 Added 0.21%	168,621 $4.08 Million
Q4 2021 Feb 09, 2022	BUY	$16.79 - $27.09 $5,423 - $8,750	323 Added 0.19%	168,276 $3.93 Million
Q3 2021 Nov 09, 2021	BUY	$15.78 - $24.77 $31,370 - $49,242	1,988 Added 1.2%	167,953 $2.79 Million
Q2 2021 Aug 04, 2021	BUY	$19.4 - $27.42 $99,851 - $141,130	5,147 Added 3.2%	165,965 $4.05 Million
Q1 2021 Apr 29, 2021	BUY	$25.02 - $54.99 $2.7 Million - $5.93 Million	107,772 Added 203.17%	160,818 $4.15 Million
Q4 2020 Feb 09, 2021	BUY	$41.04 - $56.79 $924,220 - $1.28 Million	22,520 Added 73.77%	53,046 $2.84 Million
Q3 2020 Nov 05, 2020	BUY	$36.42 - $57.0 $1.11 Million - $1.74 Million	30,526 New	30,526 $1.26 Million

Others Institutions Holding ACAD

# of Institutions

281

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.71B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empire Life Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Empire Life Investments Inc. with notifications on news.

Account